<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-52fc-3a32-0153-1a3981870b45</uuid><title>Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)</title><shortTitle>CMS144</shortTitle><emeasureid>144</emeasureid><guid>8439f671-2932-4d4c-88ca-ea5faeacc89a</guid><version>5.2.000</version><nqfid extension="2908" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3d61-56a7-013e-666032c944fd"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="83e9797c-adec-4446-8c35-3ffd5d981c66">PCPI(R) Foundation (PCPI[R])</steward><developers><developer id="d041e15c-a7a0-41b8-be5b-87340ecd14bc">American Medical Association (AMA)</developer><developer id="83e9797c-adec-4446-8c35-3ffd5d981c66">PCPI(R) Foundation (PCPI[R])</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) &lt; 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge</description><copyright>Copyright 2015 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.</copyright><disclaimer>The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. &#xD;
&#xD;
The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. &#xD;
&#xD;
Commercial uses of the Measures require a license agreement between the user and the PCPI(R) Foundation (PCPI[R]), the American Medical Association (AMA), American College of Cardiology (ACC) or the American Heart Association (AHA).  Neither the AMA, nor ACC, nor AHA, nor the AMA-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI), now known as the PCPI, nor their members shall be responsible for any use of the Measures. &#xD;
&#xD;
AMA and PCPI encourage use of the Measures by other health care professionals, where appropriate.&#xD;
&#xD;
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.&#xD;
 &#xD;
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, ACC, AHA, the PCPI and its members and former members of the AMA-PCPI disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications. &#xD;
&#xD;
CPT(R) contained in the Measure specifications is copyright 2004-2015 American Medical Association. LOINC(R) is copyright 2004-2015 Regenstrief Institute, Inc. This material contains SNOMED CLINICAL TERMS (SNOMED CT[R]) copyright 2004-2015 International Health Terminology Standards Development Organisation (IHTSDO). ICD-10 is copyright 2015 World Health Organization. All Rights Reserved.&#xD;
&#xD;
Due to technical limitations, registered trademarks are indicated by (R) or [R].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount/><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Beta-blockers are recommended for all patients with stable heart failure and left ventricular systolic dysfunction, unless contraindicated. Treatment should be initiated as soon as a patient is diagnosed with left ventricular systolic dysfunction and does not have low blood pressure, fluid overload, or recent treatment with an intravenous positive inotropic agent. Beta-blockers have been shown to lessen the symptoms of heart failure, improve the clinical status of patients, reduce future clinical deterioration, and decrease the risk of mortality and the combined risk of mortality and hospitalization.</rationale><recommendations>Use of 1 of the 3 beta blockers proven to reduce mortality (eg, bisoprolol, carvedilol, and sustained-release metoprolol succinate) is recommended for all patients with current or prior symptoms of HFrEF [heart failure with reduced ejection fraction], unless contraindicated, to reduce morbidity and mortality. (Class I, Level of Evidence: A)  (ACCF/AHA, 2013)&#xD;
&#xD;
Treatment with a beta blocker should be initiated at very low doses [see excerpt from guideline table below] followed by gradual increments in dose if lower doses have been well tolerated... Clinicians should make every effort to achieve the target doses of the beta blockers shown to be effective in major clinical trials. Even if symptoms do not improve, long-term treatment should be maintained to reduce the risk of major clinical events. Abrupt withdrawal of treatment with a beta blocker can lead to clinical deterioration and should be avoided.  (ACCF/AHA, 2013)&#xD;
&#xD;
Drugs Commonly Used for Stage C HFrEF (abbreviated to align with focus of measure to include only Beta-blocker therapy)&#xD;
Drug                               Initial Daily Dose(s)       Maximum Doses(s)       Mean Doses Achieved in Clinical &#xD;
                                                                                                                                                Trials&#xD;
Beta Blockers&#xD;
Bisoprolol                         1.25 mg once               10 mg once                   8.6 mg/d&#xD;
Carvedilol                         3.125 mg twice             50 mg twice                  37 mg/d&#xD;
Carvedilol  CR                   10 mg once                  80 mg once                   N/A&#xD;
Metoprolol succinate         12.5 to 25 mg once        200 mg once                159 mg/d&#xD;
extended release&#xD;
(metoprolol CR/XL)&#xD;
&#xD;
For the hospitalized patient:&#xD;
In patients with HFrEF experiencing a symptomatic exacerbation of HF requiring hospitalization during chronic&#xD;
maintenance treatment with GDMT[guideline-directed medical therapy; GDMT represents optimal medical therapy as defined by ACCF/AHA guideline-recommended therapies (primarily Class I)], it is recommended that GDMT be continued in the absence of hemodynamic instability or contraindications. (Class I, Level of Evidence: B)  (ACCF/AHA, 2013)&#xD;
&#xD;
Initiation of beta-blocker therapy is recommended after optimization of volume status and successful discontinuation of intravenous diuretics, vasodilators, and inotropic agents. Beta-blocker therapy should be initiated at a low dose and only in stable patients. Caution should be used when initiating beta blockers in patients who have required inotropes during their hospital course.  (Class I, Level of Evidence: B)  (ACCF/AHA, 2013)</recommendations><improvementNotations>Higher score indicates better quality</improvementNotations><references><reference>Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147-239.</reference></references><definitions>Prescribed-Outpatient setting: prescription given to the patient for beta-blocker therapy at one or more visits in the measurement period OR patient already taking beta-blocker therapy as documented in current medication list &#xD;
&#xD;
Prescribed-Inpatient setting: prescription given to the patient for beta-blocker therapy at discharge OR beta-blocker therapy to be continued after discharge as documented in the discharge medication list</definitions><guidance>LVEF &lt; 40% corresponds to qualitative documentation of moderate dysfunction or severe dysfunction.&#xD;
&#xD;
To satisfy this measure, it must be reported for all heart failure patients at least once during the measurement period if seen in the outpatient setting.  If the patient has an eligible inpatient discharge during the measurement period, as defined in the measure logic, it is expected to be reported at each hospital discharge.&#xD;
&#xD;
Beta-blocker therapy:&#xD;
-For patients with prior LVEF &lt; 40%, beta-blocker therapy should include bisoprolol, carvedilol, or sustained release metoprolol succinate.&#xD;
&#xD;
The requirement of "Count &gt;=2 of Encounter, Performed" is to establish that the eligible professional has an existing relationship with the patient.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>All patients aged 18 years and older with a diagnosis of heart failure</initialPopDescription><denominatorDescription>Equals Initial Population with a current or prior LVEF &lt; 40%</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Patients who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons)&#xD;
Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)&#xD;
Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the healthcare system)</denominatorExceptionsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex</supplementalData><qualityMeasureSet uuid="461d162c-51fe-400b-bbea-e2390ffffea2">None</qualityMeasureSet>
<finalizedDate value="201603101422-0600"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d61-56a7-013e-666032c944f8" name="ONC Administrative Sex"/><elementRef id="40280381-3d61-56a7-013e-666032c944f9" name="Race"/><elementRef id="40280381-3d61-56a7-013e-666032c944fa" name="Ethnicity"/><elementRef id="40280381-3d61-56a7-013e-666032c944fb" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="Occurrence A of $HFEncounters144" instance="A" instanceOf="2143DB57-9D30-4D97-8002-40F395661FEA" qdmVariable="true" uuid="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239"><relationalOp displayName="During" type="DURING"><setOp displayName="Union" type="union"><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4507" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4509" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94501" type="qdm"/><elementRef displayName="Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94503" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94505" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-666032cb4530" type="qdm"/><elementRef displayName="Discharge Services - Hospital Inpatient : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c944ff" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-666032c944fd" type="qdm"/></relationalOp></subTree><subTree displayName="Age greater equal to 18" qdmVariable="false" uuid="BDF89C05-8750-4AAE-AD98-98710F5D7F22"><functionalOp displayName="Age&gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-666032c944fd" type="qdm"/></functionalOp></subTree><subTree displayName="AVBlock DX overlaps OccA HFEncounters144 variable" qdmVariable="false" uuid="752FA722-7ABA-4D96-BC65-0746B54FB32B"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Atrioventricular Block : Diagnosis" id="5c742fee-cc05-4326-b3ce-59879e2be4a7" type="qdm"/><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="Count greater equal 2 encounters during MP" qdmVariable="false" uuid="75B6B738-89EC-4E34-BD52-9E44BE6A221F"><functionalOp displayName="Count&gt;= 2 " operatorType="Greater Than or Equal To" quantity="2" type="COUNT"><relationalOp displayName="During" type="DURING"><setOp displayName="Union" type="union"><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4507" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4509" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94501" type="qdm"/><elementRef displayName="Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94503" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94505" type="qdm"/><elementRef displayName="Patient Provider Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca450b" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-666032c944fd" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="DX HF overlaps Occ A HFEncounters144 variable" qdmVariable="false" uuid="A36B9B65-6798-4315-9DE3-E0E3A75E5A51"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Heart Failure : Diagnosis" id="6f251fa6-0b44-4c8a-b09f-c918590542f3" type="qdm"/><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="DX times 6 and Med Intolerance Allergy overlaps OccA HFEncounters144" qdmVariable="false" uuid="4119B2B6-3F61-4E13-A3E9-092F5D855044"><relationalOp displayName="Overlaps" type="Overlap"><setOp displayName="Union" type="union"><elementRef displayName="Arrhythmia : Diagnosis" id="333993b1-8394-4e10-8b22-ada1406cad87" type="qdm"/><elementRef displayName="Hypotension : Diagnosis" id="fa0dae4f-8cbd-48bc-8d40-d1e8714a20ea" type="qdm"/><elementRef displayName="Asthma : Diagnosis" id="f5e920f6-cefe-42ef-9513-9856be835c96" type="qdm"/><elementRef displayName="Allergy to Beta Blocker Therapy : Diagnosis" id="fea2385b-dc2f-4ac2-aedd-feb97ed60561" type="qdm"/><elementRef displayName="Beta Blocker Therapy : Medication, Intolerance" id="3a189c4b-c492-43f9-b03c-5457e3b33bac" type="qdm"/><elementRef displayName="Intolerance to Beta Blocker Therapy : Diagnosis" id="44663fc1-9504-4027-b3ef-9bd02e8f8710" type="qdm"/><elementRef displayName="Bradycardia : Diagnosis" id="7b940a49-750c-45b2-b3af-796bb9b7641f" type="qdm"/><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Allergy" id="6bc20791-ff47-4eb2-8a1e-f2b180c6b860" type="qdm"/></setOp><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="EF LVSD DX LVSD SBE Occ A HFEncounters144 variable" qdmVariable="false" uuid="A87DDA65-D042-4BFB-93B4-9A18BD8224C1"><relationalOp displayName="Starts Before End Of" type="SBE"><setOp displayName="Union" type="union"><elementRef displayName="Ejection Fraction : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-666032ca450d" type="qdm"><attribute attrUUID="2ece9881-bc3b-435d-b9df-65c6c5cb20fb" comparisonValue="40" mode="Less Than" name="result" unit="%"/></elementRef><elementRef displayName="Moderate or Severe LVSD : Diagnosis" id="1ac1a77d-6e27-4e84-b202-c3adfe2eb3a3" type="qdm"/><elementRef displayName="Left Ventricular Systolic Dysfunction : Diagnosis" id="846e06d0-a41f-4ceb-802b-762c1a9206d4" type="qdm"><attribute attrUUID="32082d53-9e9e-4569-88a1-3dd24688d259" mode="Value Set" name="severity" qdmUUID="40280381-3d61-56a7-013e-666032ca4512"/></elementRef></setOp><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="HFEncounters144" qdmVariable="true" uuid="2143DB57-9D30-4D97-8002-40F395661FEA"><relationalOp displayName="During" type="DURING"><setOp displayName="Union" type="union"><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4507" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4509" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94501" type="qdm"/><elementRef displayName="Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94503" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94505" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-666032cb4530" type="qdm"/><elementRef displayName="Discharge Services - Hospital Inpatient : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c944ff" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-666032c944fd" type="qdm"/></relationalOp></subTree><subTree displayName="IP DC during MP" qdmVariable="false" uuid="ABEFA3BC-2D84-4CB3-8AC8-B754569324B2"><relationalOp displayName="During" type="DURING"><elementRef displayName="Discharge Services - Hospital Inpatient : Encounter, Performed" id="40280381-3d61-56a7-013e-666032c944ff" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-666032c944fd" type="qdm"/></relationalOp></subTree><subTree displayName="Med Active BB overlaps OccA HFEncounters144 variable" qdmVariable="false" uuid="D31E0B58-E21C-489A-BC12-9B512489AB62"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Beta Blocker Therapy for LVSD : Medication, Active" id="40280381-3d61-56a7-013e-666032ca4514" type="qdm"/><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="Med Order BB during OccA HFEncounters144 variable" qdmVariable="false" uuid="796E6F93-2BD6-4484-91FC-FB35ED8393BA"><relationalOp displayName="During" type="DURING"><elementRef displayName="Beta Blocker Therapy for LVSD : Medication, Order" id="40280381-3d61-56a7-013e-666032ca4513" type="qdm"/><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="Med order BB not done Starts during Occ A HFEncounters144 variable" qdmVariable="false" uuid="2F3A2B8B-467C-4DE3-BE61-16A5D6EDF132"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="Union" type="union"><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Order" id="fc3fbd24-f764-4d84-a73c-52e7c89ea289" type="qdm"><attribute attrUUID="861e900a-cea3-4ed8-845e-2d82852cd724" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-666032ca4516"/></elementRef><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Order" id="fc3fbd24-f764-4d84-a73c-52e7c89ea289" type="qdm"><attribute attrUUID="7802fd35-e1f9-4dde-92fb-0007478942fd" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-666032ca4517"/></elementRef><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Order" id="fc3fbd24-f764-4d84-a73c-52e7c89ea289" type="qdm"><attribute attrUUID="00980537-6982-4e37-90c7-8fcb53b3c74d" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-666032ca4518"/></elementRef></setOp><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="Most Recent Occ B HR SBSO Occ A HR" qdmVariable="false" uuid="7939ABD3-864D-4D58-A193-E87A31C2142D"><functionalOp displayName="Most Recent" type="MOST RECENT"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Occurrence B of Heart Rate : Physical Exam, Performed" id="8a192291-5fad-4e93-83f9-e362abecea06" type="qdm"/><elementRef displayName="Occurrence A of Heart Rate : Physical Exam, Performed" id="29789e9f-f7d7-4a7b-b5ff-ab082057c0db" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="NOT DX Pacer in Situ SBE OccA HFEncounters144 variable" qdmVariable="false" uuid="0307F750-5287-44C5-BDAB-994B9B918DF2"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Cardiac Pacer in Situ : Diagnosis" id="4f84c153-fbfd-4cb9-ad14-c2fb8364d5ca" type="qdm"/><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="NOT Pacer Device SBE OccA HFEncounters144 variable" qdmVariable="false" uuid="3561B03E-6219-44C9-8E6B-A20D9CD96A2A"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Cardiac Pacer : Device, Applied" id="c756a1a4-5c56-4620-b014-1f6a8a740d76" type="qdm"/><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="OccA HR result during OccA HFEncounters144 variable" qdmVariable="false" uuid="B540C0BE-2269-40A6-A9D1-72C70DCA76CD"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of Heart Rate : Physical Exam, Performed" id="29789e9f-f7d7-4a7b-b5ff-ab082057c0db" type="qdm"><attribute attrUUID="7eff7b18-64ca-4a56-b60b-e49b18e28516" comparisonValue="50" mode="Less Than" name="result" unit="bpm"/></elementRef><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree><subTree displayName="OccB HR result during OccA HFEncounters144" qdmVariable="false" uuid="5903DBB1-83AA-4FDD-B118-79C7C191375E"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence B of Heart Rate : Physical Exam, Performed" id="8a192291-5fad-4e93-83f9-e362abecea06" type="qdm"><attribute attrUUID="7ad3e7f9-81ca-4268-812d-f02ec92cda54" comparisonValue="50" mode="Less Than" name="result" unit="bpm"/></elementRef><subTreeRef displayName="Occurrence A of HFEncounters144" id="86F1BD8A-41CA-4548-8FB9-1CD5D40E0239" type="subTree"/></relationalOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 2" type="initialPopulation" uuid="5ED1A428-A266-47E5-AE4F-DB97A65BB1D4"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age greater equal to 18" id="BDF89C05-8750-4AAE-AD98-98710F5D7F22" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="Count greater equal 2 encounters during MP" id="75B6B738-89EC-4E34-BD52-9E44BE6A221F" type="subTree"/><subTreeRef displayName="IP DC during MP" id="ABEFA3BC-2D84-4CB3-8AC8-B754569324B2" type="subTree"/></logicalOp><subTreeRef displayName="DX HF overlaps Occ A HFEncounters144 variable" id="A36B9B65-6798-4315-9DE3-E0E3A75E5A51" type="subTree"/></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="1E6C181E-91F6-4A61-82E0-7360C81CE3B0"><logicalOp displayName="AND" type="and"><subTreeRef displayName="EF LVSD DX LVSD SBE Occ A HFEncounters144 variable" id="A87DDA65-D042-4BFB-93B4-9A18BD8224C1" type="subTree"/></logicalOp></clause><clause displayName="Denominator Exceptions 2" type="denominatorExceptions" uuid="E9280685-6046-438D-AE45-0F7EDBA29C33"><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Most Recent Occ B HR SBSO Occ A HR" id="7939ABD3-864D-4D58-A193-E87A31C2142D" type="subTree"/><subTreeRef displayName="OccA HR result during OccA HFEncounters144 variable" id="B540C0BE-2269-40A6-A9D1-72C70DCA76CD" type="subTree"/><subTreeRef displayName="OccB HR result during OccA HFEncounters144" id="5903DBB1-83AA-4FDD-B118-79C7C191375E" type="subTree"/></logicalOp><subTreeRef displayName="Med order BB not done Starts during Occ A HFEncounters144 variable" id="2F3A2B8B-467C-4DE3-BE61-16A5D6EDF132" type="subTree"/><subTreeRef displayName="DX times 6 and Med Intolerance Allergy overlaps OccA HFEncounters144" id="4119B2B6-3F61-4E13-A3E9-092F5D855044" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="AVBlock DX overlaps OccA HFEncounters144 variable" id="752FA722-7ABA-4D96-BC65-0746B54FB32B" type="subTree"/><logicalOp displayName="AND NOT" type="andNot"><subTreeRef displayName="NOT DX Pacer in Situ SBE OccA HFEncounters144 variable" id="0307F750-5287-44C5-BDAB-994B9B918DF2" type="subTree"/><subTreeRef displayName="NOT Pacer Device SBE OccA HFEncounters144 variable" id="3561B03E-6219-44C9-8E6B-A20D9CD96A2A" type="subTree"/></logicalOp></logicalOp></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="ABBFFB54-E629-4520-875E-F6D18BC651B1"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="Med Order BB during OccA HFEncounters144 variable" id="796E6F93-2BD6-4484-91FC-FB35ED8393BA" type="subTree"/><subTreeRef displayName="Med Active BB overlaps OccA HFEncounters144 variable" id="D31E0B58-E21C-489A-BC12-9B512489AB62" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="8d38d97e-589e-4a22-881e-fa41649b54f1"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="7797c6f6-4569-4b3b-9e44-cb3de88d4daa"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="7c63e1c0-c4e8-4bc7-b458-1ac5d00acce0"/></group></measureGrouping><elementLookUp><qdm datatype="Diagnosis" id="fea2385b-dc2f-4ac2-aedd-feb97ed60561" name="Allergy to Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1177" suppDataElement="false" taxonomy="Grouping" uuid="fea2385b-dc2f-4ac2-aedd-feb97ed60561" version="1.0"/><qdm datatype="Diagnosis" id="333993b1-8394-4e10-8b22-ada1406cad87" name="Arrhythmia" oid="2.16.840.1.113883.3.526.3.366" suppDataElement="false" taxonomy="Grouping" uuid="333993b1-8394-4e10-8b22-ada1406cad87" version="1.0"/><qdm datatype="Diagnosis" id="f5e920f6-cefe-42ef-9513-9856be835c96" name="Asthma" oid="2.16.840.1.113883.3.526.3.362" suppDataElement="false" taxonomy="Grouping" uuid="f5e920f6-cefe-42ef-9513-9856be835c96" version="1.0"/><qdm datatype="Diagnosis" id="5c742fee-cc05-4326-b3ce-59879e2be4a7" name="Atrioventricular Block" oid="2.16.840.1.113883.3.526.3.367" suppDataElement="false" taxonomy="Grouping" uuid="5c742fee-cc05-4326-b3ce-59879e2be4a7" version="1.0"/><qdm datatype="Medication, Intolerance" id="3a189c4b-c492-43f9-b03c-5457e3b33bac" name="Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1174" suppDataElement="false" taxonomy="Grouping" uuid="3a189c4b-c492-43f9-b03c-5457e3b33bac" version="1.0"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-666032ca4513" name="Beta Blocker Therapy for LVSD" oid="2.16.840.1.113883.3.526.3.1184" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4513" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Active" id="40280381-3d61-56a7-013e-666032ca4514" name="Beta Blocker Therapy for LVSD" oid="2.16.840.1.113883.3.526.3.1184" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4514" version="1.0"/><qdm datatype="Medication, Order" id="fc3fbd24-f764-4d84-a73c-52e7c89ea289" name="Beta Blocker Therapy Ingredient" oid="2.16.840.1.113883.3.526.3.1493" suppDataElement="false" taxonomy="Grouping" uuid="fc3fbd24-f764-4d84-a73c-52e7c89ea289" version="1.0"/><qdm datatype="Medication, Allergy" id="6bc20791-ff47-4eb2-8a1e-f2b180c6b860" name="Beta Blocker Therapy Ingredient" oid="2.16.840.1.113883.3.526.3.1493" suppDataElement="false" taxonomy="Grouping" uuid="6bc20791-ff47-4eb2-8a1e-f2b180c6b860" version="1.0"/><qdm datatype="Patient Characteristic Birthdate" id="ad3c222d-67dd-4bcf-a2ca-bf6c510ef00d" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="ad3c222d-67dd-4bcf-a2ca-bf6c510ef00d" version="1.0"/><qdm datatype="Diagnosis" id="7b940a49-750c-45b2-b3af-796bb9b7641f" name="Bradycardia" oid="2.16.840.1.113883.3.526.3.412" suppDataElement="false" taxonomy="Grouping" uuid="7b940a49-750c-45b2-b3af-796bb9b7641f" version="1.0"/><qdm datatype="Device, Applied" id="c756a1a4-5c56-4620-b014-1f6a8a740d76" name="Cardiac Pacer" oid="2.16.840.1.113883.3.526.3.1193" suppDataElement="false" taxonomy="Grouping" uuid="c756a1a4-5c56-4620-b014-1f6a8a740d76" version="1.0"/><qdm datatype="Diagnosis" id="4f84c153-fbfd-4cb9-ad14-c2fb8364d5ca" name="Cardiac Pacer in Situ" oid="2.16.840.1.113883.3.526.3.368" suppDataElement="false" taxonomy="Grouping" uuid="4f84c153-fbfd-4cb9-ad14-c2fb8364d5ca" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4507" name="Care Services in Long-Term Residential Facility" oid="2.16.840.1.113883.3.464.1003.101.12.1014" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4507" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032c944ff" name="Discharge Services - Hospital Inpatient" oid="2.16.840.1.113883.3.464.1003.101.12.1007" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032c944ff" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-666032ca450d" name="Ejection Fraction" oid="2.16.840.1.113883.3.526.3.1134" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca450d" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d61-56a7-013e-666032c944fa" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d61-56a7-013e-666032c944fa" version="1"/><qdm datatype="Patient Characteristic Expired" id="e5bf4b7f-c0bb-47f8-bbde-2f987de8dac2" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="e5bf4b7f-c0bb-47f8-bbde-2f987de8dac2" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032cb4530" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032cb4530" version="1.0"/><qdm datatype="Diagnosis" id="6f251fa6-0b44-4c8a-b09f-c918590542f3" name="Heart Failure" oid="2.16.840.1.113883.3.526.3.376" suppDataElement="false" taxonomy="Grouping" uuid="6f251fa6-0b44-4c8a-b09f-c918590542f3" version="1.0"/><qdm datatype="Physical Exam, Performed" id="29789e9f-f7d7-4a7b-b5ff-ab082057c0db" instance="Occurrence A" name="Heart Rate" oid="2.16.840.1.113883.3.526.3.1176" suppDataElement="false" taxonomy="Grouping" uuid="29789e9f-f7d7-4a7b-b5ff-ab082057c0db" version="1.0"/><qdm datatype="Physical Exam, Performed" id="8a192291-5fad-4e93-83f9-e362abecea06" instance="Occurrence B" name="Heart Rate" oid="2.16.840.1.113883.3.526.3.1176" suppDataElement="false" taxonomy="Grouping" uuid="8a192291-5fad-4e93-83f9-e362abecea06" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca4509" name="Home Healthcare Services" oid="2.16.840.1.113883.3.464.1003.101.12.1016" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4509" version="1"/><qdm datatype="Diagnosis" id="fa0dae4f-8cbd-48bc-8d40-d1e8714a20ea" name="Hypotension" oid="2.16.840.1.113883.3.526.3.370" suppDataElement="false" taxonomy="Grouping" uuid="fa0dae4f-8cbd-48bc-8d40-d1e8714a20ea" version="1.0"/><qdm datatype="Diagnosis" id="44663fc1-9504-4027-b3ef-9bd02e8f8710" name="Intolerance to Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1178" suppDataElement="false" taxonomy="Grouping" uuid="44663fc1-9504-4027-b3ef-9bd02e8f8710" version="1.0"/><qdm datatype="Diagnosis" id="846e06d0-a41f-4ceb-802b-762c1a9206d4" name="Left Ventricular Systolic Dysfunction" oid="2.16.840.1.113883.3.526.3.1091" suppDataElement="false" taxonomy="Grouping" uuid="846e06d0-a41f-4ceb-802b-762c1a9206d4" version="1.0"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013e-666032c944fd" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013e-666032c944fd" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-666032ca4516" name="Medical Reason" oid="2.16.840.1.113883.3.526.3.1007" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4516" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-666032ca4512" name="Moderate or Severe" oid="2.16.840.1.113883.3.526.3.1092" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4512" version="1"/><qdm datatype="Diagnosis" id="1ac1a77d-6e27-4e84-b202-c3adfe2eb3a3" name="Moderate or Severe LVSD" oid="2.16.840.1.113883.3.526.3.1090" suppDataElement="false" taxonomy="Grouping" uuid="1ac1a77d-6e27-4e84-b202-c3adfe2eb3a3" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94501" name="Nursing Facility Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1012" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032c94501" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94503" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032c94503" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-666032c944f8" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3d61-56a7-013e-666032c944f8" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032c94505" name="Outpatient Consultation" oid="2.16.840.1.113883.3.464.1003.101.12.1008" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032c94505" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-666032ca450b" name="Patient Provider Interaction" oid="2.16.840.1.113883.3.526.3.1012" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca450b" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-666032ca4517" name="Patient Reason" oid="2.16.840.1.113883.3.526.3.1008" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4517" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d61-56a7-013e-666032c944fb" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3d61-56a7-013e-666032c944fb" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d61-56a7-013e-666032c944f9" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d61-56a7-013e-666032c944f9" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-666032ca4518" name="System Reason" oid="2.16.840.1.113883.3.526.3.1009" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-666032ca4518" version="1"/><qdm datatype="Physical Exam, Performed" id="37be61ad-7653-4872-8511-8d5f8969f781" name="Heart Rate" oid="2.16.840.1.113883.3.526.3.1176" suppDataElement="false" taxonomy="Grouping" uuid="37be61ad-7653-4872-8511-8d5f8969f781" version="1.0"/></elementLookUp></measure>